Home » News » Awards & Advancement » Perrigo names board of directors

Perrigo names board of directors

Friday, December 20, 2013

Dublin, Ireland-based Perrigo has announced the appointment of its board of directors, effective until Perrigo’s annual general meeting scheduled for November 2014. The appointment of the Perrigo board follows the completion of Perrigo’s acquisition of Elan in a cash and stock transaction valued at approximately $8.6 billion. The transaction will create a global healthcare company with a growth profile.

Joseph C. Papa, president and CEO of Perrigo, has been named chairman. Gary K. Kunkle, Jr. has been named lead independent director. Papa will lead an 11-member board comprised of all of the former members of the Perrigo board. The board will have several standing committees, including an audit committee, remuneration committee and nominating and governance committee.

Perrigo’s board now includes Laurie Brlas, Gary M. Cohen, Jacqualyn A. Fouse, David T. Gibbons, Ran Gottfried, Ellen R. Hoffing, Michael J. Jandernoa, Gary K. Kunkle, Jr., Herman Morris, Jr., Joseph C. Papa and Ben-Zion Zilberfarb.

Brlas has been a director of Perrigo since August 2003 and was chair of the audit committee since October 2004. In September 2013, Brlas was appointed executive vice president and chief financial officer of Newmont Mining, a producer of gold and copper, headquartered in Colorado. From October 2012 to July 2013, Brlas was executive vice president and president of Global Operations of Cliffs Natural Resources (formerly Cleveland-Cliffs), the largest producer of iron ore pellets in North America from 2008 through September 2012 as executive vice president and chief financial officer, as senior vice president, chief financial officer from 2006 to 2008, and senior vice president, chief financial officer and treasurer from 2006 to 2007.

Previously, Brlas was senior vice president and chief financial officer of STERIS, a provider of healthcare products, from 2000 through 2006. From 1995 through 2000, Brlas held various positions with Office Max, most recently as senior vice president and corporate controller. Brlas also was a director for Nova Chemicals from September 2008 to July 2009.

Cohen has been a director of Perrigo since January 2003 and was lead independent director from August 2008 to August 2009. Since 2006, he has been executive vice president of Becton, Dickinson and Company (BD), a provider of medical supplies, devices, laboratory equipment and diagnostic systems. He also was president of BD Medical, one of three business segments of BD, from 1999 until 2006. Cohen has been an executive officer of BD in various capacities since 1996. Mr. Cohen presently is chairperson of the Centers for Disease Control and Prevention (CDC) Foundation, director of the U.S. Fund for UNICEF, a director of the Accordia Global Health Foundation, director and acting CEO of GBCHealth, director of Together for Girls and also is a commissioner on the UN Commission for Life-Saving Commodities, chairperson of the CDC Corporate Roundtable and an advisor to the Clinton Global Initiative and the Massachusetts General Hospital Center for Global Health.

Fouse has been a director and member of the Audit Committee since November 2012. Fouse joined Celgene, a global biopharmaceutical company, in September 2012 as senior vice president and chief financial officer and currently is executive vice president and chief financial officer. From 2007 until September 2010, she was chief financial officer for Bunge, a global agribusiness and food company. From 2002 to 2007, Fouse was senior vice president, chief financial officer and corporate strategy, at Alcon Laboratories, a NYSE-listed eye care company. Previously, Fouse was chief financial officer of Swissair Group in Switzerland, 2001 to 2002, and she was group treasurer of Nestle in Switzerland from 1999 to 2001. Fouse previously held various senior level financial positions in both the U.S. and Switzerland with both Alcon and Nestle from 1986 to 1999. She also held positions with LTV Aerospace and Defense and Celanese Chemical from 1983 to 1986. Fouse has been on the board of Dick’s Sporting Goods, a U.S. retailer of sporting goods and athletic apparel since September 2010 and in May 2013 was appointed chair of the audit committee. Fouse also was on the development board and the College of Business Administration Advisory Board of the University of Texas at Arlington and on the advisory board of Texas Christian University.

Gibbons has been a director of Perrigo since June 2000. Between March 2008 and February 2009, he was interim chief executive officer of Cott, a provider of non-alcoholic beverages and store brand soft drinks. He has worked on Cott’s board since 2007 and currently is chairman. Gibbons was executive chairman of Perrigo from 2006 to March 2007. Previously, Gibbons was the president and chief executive officer of Perrigo from 2000 to 2006 and as chairman of the board from 2003 to 2007. He was president of Rubbermaid Europe from 1997 to 1999 and as president of Rubbermaid Home Products from 1995 to 1997. Previously,

Gibbons worked in a variety of general management, sales and marketing positions during his 27-year career with 3M. Gibbons also was a director of Robbins & Myers, a supplier of application-critical equipment and systems to the global pharmaceutical, energy and industrial markets, from 2002 to January 2010.

Gottfried has been a director of Perrigo since February 2006. From 2006 until December 2008, Gottfried was chairman and CEO of Powerpaper, a developer and manufacturer of micro electrical cosmetic and pharmaceutical patches. Since 1975 he has been a CEO, consultant and director of private companies in Israel and Europe in the areas of retail and distribution, pharmaceuticals, and telecommunications. From 2001 to 2005, he was chairman of Magnolia Silver Jewelry. Gottfried also was an advisor to Careline-Neca, a consumer division of Perrigo’s Israeli subsidiary from 2004 to 2007. Gottfried was a director of Agis from 2003 until its acquisition by Perrigo in 2005. Gottfried also was a director of Bezeq, an Israel telecommunications provider from 2005 until April 2010.

Hoffing has been a director of Perrigo since July 2008. Since September 2009, Hoffing has been a chief operating officer and co-president of Neos Therapeutics, a privately-held specialty pharmaceutical company that focuses on extended release liquid and orally disintegrating tablet drug development. From 2006 until September 2009, she was president and chief executive officer of Applied NeuroSolutions, a development stage biopharmaceutical company focused on diagnostics and therapeutics for the treatment of Alzheimer’s disease. She has been chairman of Applied NeuroSolutions’ board from 2007 to January 2011 and was a director since 2006. Hoffing’s experience in the pharmaceutical industry includes senior positions at American Pharmaceutical Partners, in 2005, Baxter Healthcare, from 2002 to 2005, and G.D. Searle, from 1983 to 2000.

Jandernoa has been a director of Perrigo since January 1981 and has been the chair of the Compensation Committee since October 2007. He was Perrigo’s chief executive officer from 1988 to 2000 and as chairman of the board from 1991 to 2003. Jandernoa also previously worked in various other executive capacities with Perrigo since 1979. He is a general partner of 42North Partners; was a director of Fifth Third Bank—West Michigan, a Michigan banking corporation, from 2004 to December 2009; and a director of Steelcase, a manufacturer of casegood products and furniture systems for the office furniture industry from 2002 to March 2010. Jandernoa was on the board of the Strategic Economic Investment and Commercial Board (SEIC) (formerly Michigan Technology Tri-Corridor) through early 2011. He currently works as first vice chair of the Business Leaders of Michigan.

Kunkle has been a director of Perrigo since October 2002 and has been lead independent director from august 2007 to August 2008 and since August 2009. He also was the chair of the Compensation Committee from 2006 to 2007. Kunkle was chairman and chief executive officer of DENTSPLY International, a manufacturer and marketer of products for the professional dental market, from 2004 until his retirement in 2006. He previously was president and chief operating officer of DENTSPLY from 1997 to 2003. He also was a director of that company from 2002 to 2006. From 1994 to 1996, he was president of Vistakon, a division of Johnson & Johnson.

Morris has been a director of Perrigo since December 1999 and was chair of the Nominating & Governance Committee since October 2007. Since October 2009 he has been City Attorney of the City of Memphis. From 2006 to October 2009, he was in the private practice of law in Memphis, Tennessee. In 2006, Morris was vice president and general counsel of Pinnacle Airlines. Morris was a partner in the Baker, Donaldson, Bearman, Caldwell and Berkowitz law firm in Memphis, Tennessee from 2004 to 2006. He was president and chief executive officer of Memphis Light, Gas and Water Division from 1997 until 2004.

Papa joined Perrigo in October 2006 as president and chief executive officer, was elected to the board in November 2006 and was appointed chairman in October 2007. He previously was chairman and chief executive officer of the Pharmaceutical and Technologies Services segment of Cardinal Health from 2004 to October 2006. Previously, he was president and chief operating officer of Watson Pharmaceuticals from 2001 to 2004. Additionally, he has held management positions at DuPont Pharmaceuticals, Pharmacia, G.D. Searle & Company and Novartis. Papa has been a director of Smith & Nephew, a developer of advanced orthopedic medical devices since, August 2008.

Zilberfarb has been a director of Perrigo since February 2007. Since 1978 he has been a consultant and director for private and public companies in banking, insurance and private capital. He also has been a professor of economics at Bar-Ilan University and the Edmond de Rothschild Professor of Global Asset Management at Netanya Academic College since 1988 and 2004, respectively. From 1998 to 1999 he was director general of Israel’s Ministry of Finance. He is a board member and chairman of the Audit Committee and member of the Finance Committee for Delek Group, a holding and management company investing in Israel and abroad; a board member and chairman of the finance committee for Brimag Digital Age, a distributor of electrical appliances, from 2004 to 2007 and since February 2012. He was a board member and chairman of the Risk Management Committee for the Israel Discount Bank, from 2006 to 2012; a board member and audit committee member of FundTech from 2002 to 2007; a board member and chairman of the audit committee of Partner Communication, a cellular phone company, from 2000 to 2006; and a board member and chairman of the finance committee for Engel Resources, a construction company from January 2011 to May 2013.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!